These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27068973)

  • 1. The complexity of signalling mediated by the glucagon-like peptide-1 receptor.
    Fletcher MM; Halls ML; Christopoulos A; Sexton PM; Wootten D
    Biochem Soc Trans; 2016 Apr; 44(2):582-8. PubMed ID: 27068973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function.
    Koole C; Pabreja K; Savage EE; Wootten D; Furness SG; Miller LJ; Christopoulos A; Sexton PM
    Biochem Soc Trans; 2013 Feb; 41(1):172-9. PubMed ID: 23356279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonists.
    Fletcher MM; Halls ML; Zhao P; Clydesdale L; Christopoulos A; Sexton PM; Wootten D
    Biochem Pharmacol; 2018 Oct; 156():406-419. PubMed ID: 30195733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.
    Hager MV; Clydesdale L; Gellman SH; Sexton PM; Wootten D
    Biochem Pharmacol; 2017 Jul; 136():99-108. PubMed ID: 28363772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.
    Koole C; Savage EE; Christopoulos A; Miller LJ; Sexton PM; Wootten D
    Mol Endocrinol; 2013 Aug; 27(8):1234-44. PubMed ID: 23864649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells.
    Marzook A; Tomas A; Jones B
    Front Endocrinol (Lausanne); 2021; 12():678055. PubMed ID: 34040588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of ligand-receptor binding kinetics on GLP-1R signalling.
    Zhao P; Truong TT; Merlin J; Sexton PM; Wootten D
    Biochem Pharmacol; 2022 May; 199():114985. PubMed ID: 35300966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-converting enzyme-1 regulates glucagon-like peptide-1 receptor signalling and resensitisation.
    Lu J; Willars GB
    Biochem J; 2019 Feb; 476(3):513-533. PubMed ID: 30626614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
    Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
    Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 receptor mediated control of cardiac energy metabolism.
    Al Batran R; Almutairi M; Ussher JR
    Peptides; 2018 Feb; 100():94-100. PubMed ID: 29412838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
    Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
    J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
    Thompson A; Kanamarlapudi V
    Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R).
    Koole C; Reynolds CA; Mobarec JC; Hick C; Sexton PM; Sakmar TP
    J Biol Chem; 2017 Apr; 292(17):7131-7144. PubMed ID: 28283573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects.
    Zhang H; Sturchler E; Zhu J; Nieto A; Cistrone PA; Xie J; He L; Yea K; Jones T; Turn R; Di Stefano PS; Griffin PR; Dawson PE; McDonald PH; Lerner RA
    Nat Commun; 2015 Dec; 6():8918. PubMed ID: 26621478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor.
    Wootten D; Reynolds CA; Smith KJ; Mobarec JC; Furness SG; Miller LJ; Christopoulos A; Sexton PM
    Biochem Pharmacol; 2016 Oct; 118():68-87. PubMed ID: 27569426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics.
    El Eid L; Reynolds CA; Tomas A; Ben Jones
    Pharmacol Res; 2022 Oct; 184():106411. PubMed ID: 36007775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1.
    Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B
    Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling.
    Tomas A; Jones B; Leech C
    J Mol Biol; 2020 Mar; 432(5):1347-1366. PubMed ID: 31446075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.
    Buenaventura T; Bitsi S; Laughlin WE; Burgoyne T; Lyu Z; Oqua AI; Norman H; McGlone ER; Klymchenko AS; Corrêa IR; Walker A; Inoue A; Hanyaloglu A; Grimes J; Koszegi Z; Calebiro D; Rutter GA; Bloom SR; Jones B; Tomas A
    PLoS Biol; 2019 Aug; 17(8):e3000097. PubMed ID: 31430273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.